116 related articles for article (PubMed ID: 16637920)
1. Thymus and myasthenia gravis: antigen processing in the human thymus and the consequences for the generation of autoreactive T cells.
Melms A; Luther C; Stoeckle C; Pöschel S; Schroth P; Varga M; Wienhold W; Tolosa E
Acta Neurol Scand Suppl; 2006; 183():12-3. PubMed ID: 16637920
[TBL] [Abstract][Full Text] [Related]
2. Proteases, processing, and thymic selection.
Cresswell P
Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
[No Abstract] [Full Text] [Related]
3. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.
Tolosa E; Li W; Yasuda Y; Wienhold W; Denzin LK; Lautwein A; Driessen C; Schnorrer P; Weber E; Stevanovic S; Kurek R; Melms A; Bromme D
J Clin Invest; 2003 Aug; 112(4):517-26. PubMed ID: 12925692
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.
Nakagawa T; Roth W; Wong P; Nelson A; Farr A; Deussing J; Villadangos JA; Ploegh H; Peters C; Rudensky AY
Science; 1998 Apr; 280(5362):450-3. PubMed ID: 9545226
[TBL] [Abstract][Full Text] [Related]
5. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
[TBL] [Abstract][Full Text] [Related]
6. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
7. Fc gamma receptors and HLA-DR antigens on thymus cells in myasthenia gravis.
Gilhus NE; Matre R
J Neuroimmunol; 1986 Jan; 10(3):271-8. PubMed ID: 2934405
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis.
Aarli JA; Heimann P; Matre R; Thunold S; Tönder O
J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):29-34. PubMed ID: 310870
[TBL] [Abstract][Full Text] [Related]
9. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.
Schulz R; Mellor AL
J Exp Med; 1996 Oct; 184(4):1573-8. PubMed ID: 8879232
[TBL] [Abstract][Full Text] [Related]
10. Altered intrathymic T-cell repertoire in human myasthenia gravis.
Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
[TBL] [Abstract][Full Text] [Related]
11. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
Hohlfeld R; Wekerle H
J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
[TBL] [Abstract][Full Text] [Related]
12. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.
Nicolle MW; Nag B; Sharma SD; Willcox N; Vincent A; Ferguson DJ; Newsom-Davis J
J Clin Invest; 1994 Apr; 93(4):1361-9. PubMed ID: 7512979
[TBL] [Abstract][Full Text] [Related]
13. The thymus in myasthenia gravis: an immunohistologic study.
Kornstein MJ; Brooks JJ; Anderson AO; Levinson AI; Lisak RP; Zweiman B
Adv Exp Med Biol; 1985; 186():929-36. PubMed ID: 2413737
[No Abstract] [Full Text] [Related]
14. Cathepsin S dominates autoantigen processing in human thymic dendritic cells.
Stoeckle C; Quecke P; Rückrich T; Burster T; Reich M; Weber E; Kalbacher H; Driessen C; Melms A; Tolosa E
J Autoimmun; 2012 Jun; 38(4):332-43. PubMed ID: 22424724
[TBL] [Abstract][Full Text] [Related]
15. Autoreactivity between lymphocytes and thymus cells in myasthenia gravis.
Opelz G; Keesey J; Glovsky MM; Gale RP
Arch Neurol; 1978 Jul; 35(7):413-5. PubMed ID: 149529
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
Fujii Y; Hayakawa M; Inada K; Nakahara K
Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.
Honey K; Nakagawa T; Peters C; Rudensky A
J Exp Med; 2002 May; 195(10):1349-58. PubMed ID: 12021314
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
19. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
[TBL] [Abstract][Full Text] [Related]
20. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A
Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]